Your browser is no longer supported. Please, upgrade your browser.
Settings
LIFE aTyr Pharma, Inc. daily Stock Chart
LIFE [NASD]
aTyr Pharma, Inc.
Index- P/E- EPS (ttm)-13.68 Insider Own0.10% Shs Outstand3.74M Perf Week-20.57%
Market Cap14.59M Forward P/E- EPS next Y-16.98 Insider Trans0.00% Shs Float3.19M Perf Month-24.69%
Income-30.00M PEG- EPS next Q-2.74 Inst Own38.80% Short Float1.18% Perf Quarter-49.17%
Sales- P/S- EPS this Y38.30% Inst Trans-0.68% Short Ratio0.42 Perf Half Y-50.50%
Book/sh12.20 P/B0.32 EPS next Y-48.40% ROA-52.00% Target Price7.00 Perf Year-68.79%
Cash/sh11.52 P/C0.34 EPS next 5Y- ROE-81.30% 52W Range3.75 - 12.88 Perf YTD-43.80%
Dividend- P/FCF- EPS past 5Y-3.70% ROI- 52W High-72.94% Beta2.34
Dividend %- Quick Ratio4.00 Sales past 5Y- Gross Margin- 52W Low-7.08% ATR0.60
Employees42 Current Ratio4.00 Sales Q/Q- Oper. Margin- RSI (14)27.15 Volatility16.75% 12.27%
OptionableYes Debt/Eq0.48 EPS Q/Q49.30% Profit Margin- Rel Volume4.48 Prev Close3.90
ShortableYes LT Debt/Eq0.22 EarningsAug 12 AMC Payout- Avg Volume89.71K Price3.48
Recom3.00 SMA20-30.89% SMA50-37.87% SMA200-51.88% Volume153,081 Change-10.66%
Feb-14-18Downgrade JP Morgan Neutral → Underweight
Sep-07-17Initiated Piper Jaffray Overweight $7
Dec-13-16Downgrade JP Morgan Overweight → Neutral
Dec-16-15Initiated Citigroup Neutral
Jun-01-15Initiated JP Morgan Overweight $44
Jun-01-15Initiated Citigroup Buy $32
Jul-10-19 08:00AM  aTyr Pharma to Host Key Opinion Leader Call and Webcast on Sarcoidosis and the Current Treatment Landscape GlobeNewswire
Jul-01-19 08:00AM  aTyr Pharma Strengthens Board of Directors with the Appointment of Two New Members GlobeNewswire +6.48%
Jun-28-19 04:05PM  aTyr Pharma Announces Reverse Stock Split to Regain NASDAQ Compliance GlobeNewswire
May-27-19 03:41PM  Edited Transcript of LIFE earnings conference call or presentation 13-May-19 9:00pm GMT Thomson Reuters StreetEvents
May-13-19 04:27PM  Atyr Pharma: 1Q Earnings Snapshot Associated Press
04:05PM  aTyr Pharma Announces First Quarter 2019 Results and Provides Corporate Update GlobeNewswire
May-06-19 04:58PM  aTyr Pharma to Announce First Quarter 2019 Results on May 13th GlobeNewswire
Apr-16-19 08:00AM  aTyr Pharma to Host Inaugural Summit Meeting on Neuropilin-2 (NRP-2) Biology GlobeNewswire
Apr-11-19 08:00AM  aTyr Pharma Announces $5 Million Registered Direct Offering led by The Federated Kaufmann Small Cap Fund GlobeNewswire
Apr-10-19 11:05AM  Edited Transcript of LIFE earnings conference call or presentation 25-Mar-19 9:00pm GMT Thomson Reuters StreetEvents
Apr-08-19 04:00PM  aTyr Pharma to Present Poster at the American Thoracic Society 2019 International Conference GlobeNewswire +7.72%
Mar-28-19 09:00AM  Atyr Pharma (LIFE) Upgraded to Buy: Here's Why Zacks
Mar-25-19 04:16PM  Atyr Pharma: 4Q Earnings Snapshot Associated Press -9.51%
04:00PM  aTyr Pharma Announces Fourth Quarter and Full Year 2018 Results and Provides Corporate Update GlobeNewswire
03:00PM  aTyr Pharma, Inc. to Host Earnings Call ACCESSWIRE
Mar-21-19 08:00AM  aTyr Pharma Announces Poster Presentation at the 2019 American Association for Cancer Research (AACR) Annual Meeting GlobeNewswire +14.04%
Mar-18-19 04:46PM  aTyr Pharma to Announce Fourth Quarter and Full Year 2018 Financial Results on March 25th GlobeNewswire
Mar-11-19 08:00AM  aTyr Pharma Announces Research Collaboration With Global Biotherapeutics Leader CSL Behring GlobeNewswire
Mar-04-19 05:36PM  aTyr Pharma Announces Participation at March Investor Conferences GlobeNewswire -5.32%
Feb-27-19 04:00PM  aTyr Pharma Presents Compelling Preclinical Data Highlighting Potential of ATYR1923 to Regulate Myeloid Cell Biology During Lung Inflammation GlobeNewswire
Feb-21-19 06:20PM  Evolve Announces February 2019 Distributions for Evolve ETFs CNW Group
Feb-05-19 04:05PM  aTyr Pharma to Present at the BIO CEO & Investor Conference GlobeNewswire
Jan-30-19 04:00PM  aTyr Pharma Announces Research Collaboration with the University of Nebraska Medical Center and Expansion of Successful Pilot Study GlobeNewswire
Jan-16-19 04:00PM  Pangu BioPharma (an aTyr Pharma Subsidiary) and The Hong Kong University of Science and Technology Recognized for Pioneering Work Leading to New Investigational Therapeutic for Lung Disease GlobeNewswire
10:16AM  Zacks.com featured highlights include: G-III, SP Plus, Penske Automotive, aTyr and Avinger Zacks
Jan-15-19 06:23AM  What Bargain Hunting? Tap 5 Stocks With Rising P/E Zacks +8.24%
Jan-02-19 07:37PM  aTyr Pharma Announces Participation at Upcoming San Francisco Investor Events GlobeNewswire +6.92%
Dec-21-18 01:51PM  Need To Know: aTyr Pharma, Inc. (NASDAQ:LIFE) Insiders Have Been Buying Shares Simply Wall St. -6.98%
Dec-04-18 08:00AM  aTyr Pharma Announces Initiation of Phase 1b/2a Study of ATYR1923 in Patients with Pulmonary Sarcoidosis and Collaboration with the Foundation for Sarcoidosis Research (FSR) GlobeNewswire -5.36%
Nov-29-18 08:06AM  Zacks.com highlights: Asbury Automotive, OncoGenex Pharmaceuticals, aTyr Pharma, Avinger and Sunesis Pharmaceuticals Zacks
Nov-28-18 08:16PM  aTyr Pharma to Present at the BMO 2018 Prescriptions for Success Healthcare Conference GlobeNewswire
07:04AM  5 Top-Ranked Rising P/E Stocks to Lure Investors Zacks
Nov-21-18 08:50AM  Market Trends Toward New Normal in Wilhelmina International, Eyenovia, aTyr Pharma, Avinger, Viacom, and Axsome Therapeutics Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Nov-13-18 04:21PM  Atyr Pharma: 3Q Earnings Snapshot Associated Press -9.59%
04:05PM  aTyr Pharma Announces Third Quarter 2018 Operating Results and Provides Corporate Update GlobeNewswire
Nov-08-18 08:00AM  aTyr Pharma to Host Conference Call and Webcast of Third Quarter 2018 Financial Results on November 13, 2018 GlobeNewswire +6.21%
Oct-17-18 08:00AM  aTyr Pharma Presents at American Society of Human Genetics 2018 Meeting GlobeNewswire
Oct-15-18 04:30PM  aTyr Pharma Announces Leadership Transition GlobeNewswire
Sep-27-18 04:05PM  aTyr Pharma Announces Pulmonary Sarcoidosis as Disease Indication for Phase 1b/2a Clinical Study and Educational Webinar GlobeNewswire
Sep-20-18 04:38PM  aTyr Pharma to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference GlobeNewswire
Aug-30-18 05:51PM  Edited Transcript of LIFE earnings conference call or presentation 14-Aug-18 9:00pm GMT Thomson Reuters StreetEvents
08:00AM  aTyr Pharma to Present at the Baird 2018 Global Healthcare Conference GlobeNewswire
Aug-14-18 05:03PM  Atyr Pharma: 2Q Earnings Snapshot Associated Press
04:05PM  aTyr Pharma Announces Second Quarter 2018 Operating Results and Provides Corporate Update GlobeNewswire
03:00PM  aTyr Pharma, Inc. to Host Earnings Call ACCESSWIRE
Aug-08-18 04:05PM  aTyr Pharma to Host Conference Call and Webcast of Second Quarter 2018 Financial Results on August 14, 2018 GlobeNewswire
Jul-31-18 08:00AM  aTyr Pharma Appoints Jill Broadfoot as Chief Financial Officer GlobeNewswire
Jul-26-18 08:00AM  aTyr Pharma Presents Positive Lung and Skin Findings with ATYR1923 in a Translational Animal Model at the Scleroderma Foundation National Patient Education Conference GlobeNewswire
Jun-26-18 08:00AM  aTyr Pharma Announces Positive Phase 1 Data for ATYR1923 Therapeutic Candidate GlobeNewswire -8.18%
Jun-08-18 01:46PM  Edited Transcript of LIFE earnings conference call or presentation 19-Mar-18 9:00pm GMT Thomson Reuters StreetEvents +14.44%
May-31-18 08:00AM  aTyr Pharma to Present at Jefferies 2018 Global Healthcare Conference GlobeNewswire
May-17-18 07:30AM  aTyr Pharma Presents Poster on Preclinical Data from ATYR1923 Program at American Thoracic Society 2018 International Conference GlobeNewswire +14.71%
May-15-18 08:06AM  Edited Transcript of LIFE earnings conference call or presentation 14-May-18 12:00pm GMT Thomson Reuters StreetEvents -12.90%
May-14-18 06:49AM  Atyr Pharma: 1Q Earnings Snapshot Associated Press -32.61%
06:45AM  aTyr Pharma Announces First Quarter 2018 Operating Results, Program Prioritization and Corporate Restructuring GlobeNewswire
06:00AM  aTyr Pharma, Inc. to Host Earnings Call ACCESSWIRE
May-08-18 08:00AM  aTyr Pharma to Host Conference Call and Webcast of First Quarter 2018 Financial Results on May 14, 2018 GlobeNewswire
May-02-18 08:00AM  aTyr Pharma Provides Mechanistic Update on Resokine Pathway at American Academy of Immunology Annual Meeting GlobeNewswire
Mar-26-18 08:14AM  aTyr Pharma, Inc. (LIFE) Sees Hammer Chart Pattern: Time to Buy? Zacks
Mar-19-18 04:37PM  Atyr Pharma reports 4Q loss Associated Press
04:05PM  aTyr Pharma Announces Fourth Quarter and Year-End 2017 Operating Results and Provides Corporate Update GlobeNewswire
12:30PM  aTyr Pharma, Inc. to Host Earnings Call ACCESSWIRE
Mar-07-18 08:00AM  aTyr Pharma to Host Conference Call and Webcast of Full Year 2017 Financial Results on March 19, 2018 GlobeNewswire
Mar-01-18 08:00AM  aTyr Pharma to Present at Two Upcoming Investor Conferences in March GlobeNewswire
Dec-21-17 08:00AM  aTyr Pharma Announces Poster Presentation at ASCO-SITC Clinical Immuno-Oncology Symposium GlobeNewswire
Dec-07-17 08:00AM  aTyr Pharma to Participate at the BMO Prescriptions for Success Healthcare Conference GlobeNewswire
Nov-27-17 08:00AM  aTyr Pharma Doses First Subjects in Phase 1 Trial of iMod.Fc (ATYR1923) GlobeNewswire +8.75%
Nov-21-17 08:00AM  aTyr Pharma to Participate at the Piper Jaffray 29th Annual Healthcare Conference GlobeNewswire
Nov-16-17 05:14AM  Atyr Pharma reports 3Q loss Associated Press
Nov-14-17 04:05PM  aTyr Pharma Announces Third Quarter 2017 Operating Results and Provides Corporate Update GlobeNewswire
Nov-01-17 04:05PM  aTyr Pharma Announces Leadership Transition GlobeNewswire -16.67%
Oct-11-17 08:25AM  Zacks.com featured highlights include article Kraton, aTyr Pharma, Grupo Financiero Galicia, Grupo Supervielle and Calithera Biosciences Zacks +11.50%
Oct-04-17 08:16PM  How Should You Think About aTyr Pharma Incs (LIFE) Risks? Simply Wall St. +18.95%
Sep-27-17 08:00AM  aTyr Pharma to Present Final Data for Resolaris Phase 1b/2 Trial in Patients with Early-Onset Facioscapulohumeral Muscular Dystrophy at the 22nd International Annual Congress of the World Muscle Society GlobeNewswire +9.52%
Sep-05-17 11:00PM  aTyr Pharma to Present at Two Upcoming Investor Conferences in September GlobeNewswire -9.84%
Aug-28-17 06:24PM  [$$] Publicly Traded Rare Disease Drug-Maker aTyr Pharma Gets $46 Million Lift The Wall Street Journal +5.77%
07:30AM  aTyr Pharma Announces $45 Million Equity Financing GlobeNewswire
Aug-14-17 11:24PM  Atyr Pharma reports 2Q loss Associated Press +6.56%
04:05PM  aTyr Pharma Announces Second Quarter 2017 Operating Results and Provides an Update on Innovative Immunology Pipeline GlobeNewswire
Aug-10-17 08:45AM  aTyr Pharma Announces Date of Earnings Release For Second Quarter 2017 Financial Results GlobeNewswire
May-31-17 09:00AM  aTyr Pharma to Present at Jefferies 2017 Global Healthcare Conference GlobeNewswire
May-15-17 08:00AM  aTyr Pharma Announces Presentations on Interstitial Lung Disease and the iMod.Fc Program at the American Thoracic Society 2017 International Conference and Will Host an Educational Webinar GlobeNewswire
May-11-17 05:51PM  Atyr Pharma reports 1Q loss Associated Press
04:05PM  aTyr Pharma Announces First Quarter 2017 Operating Results GlobeNewswire
Apr-24-17 08:00AM  aTyr Pharma Presents Analyses of Resolaris Phase 1b/2 Trial in Patients with Limb Girdle Muscular Dystrophy 2B and Facioscapulohumeral Muscular Dystrophy at the American Academy of Neurology 69th Annual Meeting GlobeNewswire
07:30AM  aTyr Pharma Announces Promising Top-Line Results from Resolaris Phase 1b/2 Clinical Trial in Patients with Early Onset Facioscapulohumeral Muscular Dystrophy GlobeNewswire
Apr-10-17 05:00PM  aTyr Pharma Announces Appointment of Timothy P. Coughlin to its Board of Directors GlobeNewswire
Apr-03-17 08:02AM  ATYR PHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers
08:00AM  aTyr Pharma Announces Appointment of Jeffery S. Hatfield to its Board of Directors PR Newswire
Mar-29-17 09:00AM  aTyr Pharma to Present at Needham and Company 16th Annual Healthcare Conference GlobeNewswire
Mar-22-17 01:04PM  ATYR PHARMA INC Financials
Mar-16-17 04:46PM  Atyr Pharma reports 4Q loss Associated Press
04:12PM  ATYR PHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
Mar-15-17 06:00AM  aTyr Pharma Announces Issuance of US Patent That Extends Patent Protection of Physiocrines Derived From 20 out of 20 Human tRNA Synthetases PR Newswire
Mar-03-17 08:00AM  aTyr Pharma Receives EMA Orphan Drug Designation for the Treatment of Limb Girdle Muscular Dystrophy with Resolaris PR Newswire
Mar-01-17 12:30PM  aTyr Pharma Rises 16% on Orphan Drug Status Investopedia
12:30PM  aTyr Pharma Rises 16% on Orphan Drug Status at Investopedia
08:00AM  aTyr Pharma to Present at Cowen and Company 37th Annual Health Care Conference PR Newswire
Feb-28-17 08:00AM  aTyr Pharma Receives U.S. FDA Orphan Drug Designation for the Treatment of Limb Girdle Muscular Dystrophy with Resolaris PR Newswire
Feb-22-17 12:49PM  High court ruling limits international reach of patent laws Associated Press
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. Its therapeutic candidate pipeline includes ATYR1923 candidate, a fusion protein comprising the immuno-modulatory domain of histidyl tRNA synthetase fused of a human antibody that is in Phase 1b/2a clinical trial for treating patients with interstitial lung diseases (ILDs), such as pulmonary sarcoidosis; and in Phase 1 clinical trial to treat chronic hypersensitivity pneumonitis and connective tissue disease ILD. The company has a collaboration with the University of Nebraska Medical Center for the development of neuropilin-2 receptor biology; and a research collaboration and option agreement with CSL Behring for the development of product candidates derived from up to four tRNA synthetases. The company was founded in 2005 and is headquartered in San Diego, California.